• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

diabetes mellitus

Posted inMetabolism, New Drugs, Regulatory

Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus

by Mark Gubar, Tanya von Reuss and Timur Burkhanayev May 17, 2022September 8, 2022

Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.

Posted inMetabolism, New Drugs, Regulatory

Twymeeg: Completely New Drug for Treatment of Type 2 Diabetes Mellitus

by Nik Resovski and Timur Burkhanayev February 17, 2022September 8, 2022

Imeglimin is a universal anti-diabetic drug that incorporates the power of all existing glucose-lowering drugs.

Posted inMetabolism, New Drugs, Regulatory

Kerendia: New Drug for Diabetic Kidney Disease

by Mark Gubar February 16, 2022September 8, 2022

Finerenone for the treatment of diabetic nephropathy, a chronic kidney disease associated with type 2 diabetes mellitus.

Posted inAutoimmune Diseases, Clinical Trials, Metabolism

Precigen ActoBio: Innovative Treatment for Type 1 Diabetes Mellitus

by Mark Gubar June 11, 2021September 8, 2022

The autoimmune disease will be defeated by restoring immune tolerance.

obesity
Posted inMetabolism, New Drugs, Regulatory

Wegovy: Most Effective Drug for Weight Loss

by Nik Resovski and Timur Burkhanayev June 9, 2021September 8, 2022

Semaglutide can help you lose 15% of your excess weight in a year. And even more.

Posted inNeuroscience, New Drugs, Regulatory

Lybalvi: New Drug for Schizophrenia and Bipolar I Disorder

by Mark Gubar June 3, 2021September 8, 2022

Combination of olanzapine and samidorphan will prevent unwanted weight gain in patients.

Liver.
Posted inMetabolism, New Drugs, Regulatory

Lipaglyn: World’s First Drug to Treat Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease

by Tanya von Reuss and Timur Burkhanayev April 6, 2021September 8, 2022

Saroglitazar by Zydus Cadila has opened the doors to a new multi-billion dollar sector of NASH and NAFLD pharmacological treatments.

Posts pagination

Newer posts 1 2
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×